Mycobacterium tuberculosis H37Rv · ORGANISM · Mycobacterium tuberculosis H37Rv
This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.
Move to another high-traffic target or paste a specific ChEMBL target ID.
Structured disease, protein, and project context should read before the lower-level identity rail.
As of 2026-09-14Mycobacterium tuberculosis H37Rv shows approved-linked disease relevance led by drug-resistant tuberculosis. 3 more disease programs remain visible in the same review block. 1 linked drug keeps the current disease frame grounded. Use drug-resistant tuberculosis as the disease frame, then confirm a stable protein accession before cross-source reuse.
Use drug-resistant tuberculosis as the disease frame, then confirm a stable protein accession before cross-source reuse.
Mycobacterium tuberculosis H37Rv shows approved-linked disease relevance led by drug-resistant tuberculosis. 3 more disease programs remain visible in the same review block. 1 linked drug remains visible in the same block.
Start review with drug-resistant tuberculosis because it currently carries approved-linked support. Linked drugs include DELAMANID. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
Disease source · ChEMBL drug mechanism + indication proxyMycobacterium tuberculosis H37Rv
Review this target as Mycobacterium tuberculosis H37Rv.
Protein source · UniProt accession via ChEMBL component mappingKeep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.
This review treats Mycobacterium tuberculosis H37Rv as ChEMBL target CHEMBL2111188. Disease framing currently uses the Open Targets-ready proxy contract.
Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.
Choose the first block or source based on the question you are trying to answer.
Start here when your first question is whether Mycobacterium tuberculosis H37Rv still has a stable protein naming contract across sources.
Jump to Protein ContextUse this block first when you need to confirm why drug-resistant tuberculosis is currently framed as approved-linked support. It currently carries 1 linked drug in the same disease frame.
Jump to Disease ContextOpen the one-page evidence card when you want the rationale, activity base, and attribution together.
Open Review-ready CardVerify identity, organism, and the fastest next research jumps from the same page.
| Preferred Name | Mycobacterium tuberculosis H37Rv |
| Target Type | ORGANISM |
| Organism | Mycobacterium tuberculosis H37Rv |
Reviewable protein naming and mapping context for this target snapshot.
| Protein Label | Mycobacterium tuberculosis H37Rv |
| UniProt Accession | N/A |
Mycobacterium tuberculosis H37Rv
Review this target as Mycobacterium tuberculosis H37Rv.
Open Targets-ready disease context using the current target-indication evidence contract.
Mycobacterium tuberculosis H37Rv shows approved-linked disease relevance led by drug-resistant tuberculosis. 3 more disease programs remain visible in the same review block.
Start review with drug-resistant tuberculosis because it currently carries approved-linked support. Linked drugs include DELAMANID. This disease block keeps the Open Targets-ready contract explicit while current evidence comes from ChEMBL mechanism and indication mappings.
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 11 | 0 | — |
| BAO Format | Assays | Compounds | Avg pChEMBL |
|---|---|---|---|
| organism-based format | 7 | 0 | — |